Related Experiment Video
Updated: Mar 17, 2026

11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
14.3K
Pulse Duplicator Hydrodynamic Testing of Bioengineered Biological Heart Valves
Eric E Buse1, Stephen L Hilbert1, Richard A Hopkins1
1Cardiac Regenerative Surgery Research Laboratories of The Ward Family Heart Center, Children's Mercy Kansas City, 2401 Gillham Road, Kansas City, MO, 64108, USA.
Cardiovascular Engineering and Technology
|July 23, 2016
Summary
Decellularized heart valves show promising results for pediatric patients with congenital defects. These bioengineered valves demonstrated satisfactory performance in pre-clinical testing, suggesting potential for improved clinical outcomes.
Area of Science:
- Biomaterials Science
- Cardiovascular Engineering
- Regenerative Medicine
Background:
- Current heart valve replacements are suboptimal for pediatric congenital defects.
- Decellularized valve substitutes offer potential for better outcomes.
- Pre-clinical testing for biological valves requires specialized systems.
Purpose of the Study:
- To assess the hydrodynamic performance of bioengineered pulmonary valves.
- To evaluate the mechanical behavior of associated sinus and arterial tissue.
- To establish testing guidelines for non-crosslinked biological heart valves.
Main Methods:
- Utilized a custom pulse duplicator for testing intact biological valved conduits.
- Evaluated valve hydrodynamic performance under simulated physiological conditions.
- Assessed mechanical properties using biaxial loading on valve-associated tissues.
Main Results:
- Decellularized and ECM-conditioned valves exhibited reduced pressure gradients.
- Effective orifice area increased for decellularized and ECM-conditioned valves.
- ECM conditioning enhanced elastic modulus but reduced tissue stretch.
Conclusions:
- Decellularization and ECM conditioning did not compromise scaffold integrity.
- The bioengineered valves demonstrated satisfactory benchtop performance.
- These findings support the use of decellularized valves in pre-clinical settings for pediatric applications.

